Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Tumor necrosis factor antisense therapy fights alcoholic liver disease
April 19th, 2005
Tumor necrosis factor antisense therapy fights alcoholic liver disease. According to published research from the United States, "elevated serum tumor necrosis factor alpha (TNF-alpha) levels predict mortality in patients with alcoholic liver disease. Administration of anti-TNF-alpha antibodies, obliteration of Kupffer cells or gut sterilization protect against ethanol-induced hepatocellular injury in animal models. In this study, we evaluated the in vivo efficacy of an antisense phosphorothioate oligodeoxynucleotide (S-ODN) targeted against TNF-alpha mRNA (TJU-2755)." "Naive rats that were administered TJU-2755 (10 mg/(kg body weight (BW)/day) for 2...
Source: Cancer Weekly (2005-04-19)
|
